Renal Cancer - Results from #5620

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients July 15, 2016

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma July 15, 2016

Surveillance of Small Renal Masses July 14, 2016

Increased expression of kindlin-2 is correlated with hematogenous metastasis and poor prognosis in patients with clear cell renal cell carcinoma July 13, 2016

Prevention and management of osteonecrosis of the jaw secondary to bone-targeted therapy in patients with kidney cancer July 8, 2016

Clinicopathologic Features of Translocation Renal Cell Carcinoma July 7, 2016

Contemporary Issues Surrounding Small Renal Masses: Evaluation, Diagnostic Biopsy, Nephron Sparing, and Novel Treatment Modalities July 6, 2016

Insights into the Genetic Basis of the Renal Cell Carcinomas from the Cancer Genome Atlas (TCGA) July 5, 2016

Disseminated intravascular coagulation following administration of sunitinib July 4, 2016

Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma July 4, 2016

Clinical Experience of Escalated Sunitinib Dose in Select Patients With Metastatic Renal Cell Carcinoma July 1, 2016

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types July 1, 2016

Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families July 1, 2016

Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer June 30, 2016

Expression and clinicopathological correlations of retinoid acid receptor responder protein 1 in renal cell carcinomas June 29, 2016

Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma June 29, 2016

Role of mTOR Inhibitors in Kidney Disease June 28, 2016

Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites June 28, 2016

Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients June 27, 2016

A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma June 27, 2016

Page 282 of 456